Clinical Integrative Research Center of Atlanta, Panda Neurology | Atlanta, GA

Research site

Location

5887 Glenridge Dr., Suite 140, Atlanta, Georgia, United States of America

Site insights

Top conditions

Top treatments

ZX008

Soticlestat

Cannabidiol

Fenfluramine Hydrochloride

Eslicarbazepine Acetate

Amitriptyline

Eptinezumab

Galcanezumab

Ubrogepant

AMG 334

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Cristy Miles

Verified by this site

Active trials

5 of 22 total trials

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine (REBUILD-1)

The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17 years of age for the preventive treatme...

Active, not recruiting

Episodic Migraine

Drug: Galcanezumab

Drug: Placebo

A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

This is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep, as compared with placebo, in the tre...

Not yet enrolling

Migraine

Drug: Placebo

Drug: Elismetrep

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

This study will evaluate the efficacy and safety of SPN-812 (viloxazine extended release) in children 4 to 5 years of age with ADHD.

Enrolling

Attention-Deficit/Hyperactivity Disorder

Drug: Placebo

Drug: 100mg SPN-812

Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17) (UBRO PEDS OLE)

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...

Invitation-only

Migraine

Drug: Ubrogepant

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) (Ubro Peds)

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...

Enrolling

Migraine

Drug: Placebo-Matching Ubrogepant

Drug: Ubrogepant